A proposed federal rule says that patients must be informed after mammograms if they have dense breasts.
by Carly Weeks
Drugs that target DNA repair enzymes may provide alternatives to long-term chemotherapy for some patients with pancreatic cancer.
by Kate Yandell
When visiting a friend or family member who is sick, it’s good to leave platitudes at the door.
by Michael Gavaghen
FROM THE EDITOR-IN-Chief
Hepatitis C infection, obesity and alcohol can contribute to more cases of liver cancer.
by William G. Nelson, MD, PhD
FORWARD LOOK
Surgery and radiation have similar benefits but different side effects.
by Stephen Ornes
Studies aim to identify when screening is beneficial.
by Sue Rochman
Payments can be put off during treatment and for six months after.
by Bradley Jones
Study findings suggest patient screening has been too narrow.
by Sharon Tregaskis
Similarities between cancers create path for studying new treatments.
by Cameron Walker
Survivor Profile
Rabbi Ben David was comfortable in his role of helping those in need, but he had to rely on others after his lymphoma diagnosis. The marathon runner has returned to an active life one step at a time.
by Lindsey Konkel
Survivors and advocates display their posters alongside the work of thousands of cancer researchers.
by Kevin McLaughlin
Drug developers behind the six currently approved checkpoint inhibitors discuss the pros and cons of competition in the field.
A pair of studies demonstrated encouraging clinical outcomes with two different CAR T-cell therapies for patients with advanced solid tumors.
The U.S. Food and Drug Administration has for the first time approved an immunotherapeutic for breast cancer.
Researchers are studying how to treat EGFR-positive non-small cell lung cancer that has become resistant to tyrosine kinase inhibitors.
A Lesson in Service
donate to the AACR